Science | ABNewswire

Leading Travel Aggregator | PROVAB Launches XML feed with Flights Including LCCs, Hotels, Cars, Transfers and Activities

With PROVAB, travel agencies and DMCs are deploying top travel technology solutions to increase topline and profits. PROVAB is one of the leading travel wholesalers and it has recently launched an upgraded version of Travel APIs with flights which include … Continue reading →

California Libraries Now Offer Free Ecosense EcoBlu Radon Monitors Through CDPH Program

A new statewide initiative expands radon awareness and provides residents with free, easy-to-use digital testing devices. Ecosense announced its partnership with the California Department of Public Health (CDPH) Indoor Radon Program to provide digital radon detection technology to all residents … Continue reading →

Breast Cancer Clinical Trial Pipeline Gains Momentum: 250+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Breast Cancer Pipeline Insight 2025” report provides comprehensive insights about 250+ Breast Cancer companies and 300+ pipeline drugs in the Breast Cancer pipeline landscape. It covers the Breast Cancer pipeline drugs profiles, including clinical and nonclinical stage products. It … Continue reading →

Wiskott-Aldrich Syndrome Clinical Trial Pipeline Expands as 5+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Wiskott-Aldrich Syndrome Pipeline Insight 2025” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in the Wiskott-Aldrich Syndrome pipeline landscape. It covers the Wiskott-Aldrich Syndrome pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Dilated Cardiomyopathy Treatment Pipeline Shows Strong Momentum as 8+ Pharma Companies in the Race | DelveInsight

DelveInsight’s “Dilated Cardiomyopathy Pipeline Insight 2025” report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in the Dilated Cardiomyopathy pipeline landscape. It covers the Dilated Cardiomyopathy pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Facioscapulohumeral Muscular Dystrophy Clinical Trial Pipeline Shows Potential with Active Contributions from 10+ Key Companies | DelveInsight

DelveInsight’s “Facioscapulohumeral Muscular Dystrophy Pipeline Insight 2025” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in the Facioscapulohumeral Muscular Dystrophy pipeline landscape. It covers the Facioscapulohumeral Muscular Dystrophy pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Small Cell Lung Cancer Clinical Trial Pipeline Accelerates as 100+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Small Cell Lung Cancer Pipeline Insight 2025” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Small Cell Lung Cancer pipeline landscape. It covers the Small Cell Lung Cancer pipeline drug profiles, including clinical and nonclinical … Continue reading →

The Secret of Life – Ancient Biotechnology Evolution

Dr. Zarkaish Ismail — whose identify means “Gold Feather” — is a biotechnology and dermatology entrepreneur and the Co-Founder-Chief Executive Officer of Kore Secrets™, a revolutionary biotechnology lab and manufacturing firm primarily based in United States, who channels deep scientific … Continue reading →

Aplastic Anemia Clinical Trial Pipeline Appears Robust With 5+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s, “Aplastic Anemia- Pipeline Insight, 2025” report provides comprehensive insights about 5+ companies and 8+ pipeline drugs in Aplastic Anemia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment … Continue reading →

Hereditary Angioedema Clinical Trial Pipeline Expands as 20+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Hereditary Angioedema Pipeline Insight, 2025,” report provides comprehensive insights about 20+ companies and 30+ pipeline drugs in Hthe ereditary Angioedema pipeline landscape. It covers the Hereditary Angioedema pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Thursday - December 25, 2025

Category Archives: Science